KA
ELV icon

Kozak & Associates’s Elevance Health ELV Stock Holding History

Kozak & Associates’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.5K Sell
64
-149
-70% -$55.3K ﹤0.01% 183
2026
Q1 		$67.2K Buy
213
+1
+0.5% +$329 0.01% 128
2025
Q4 		$78.9K Buy
212
+1
+0.5% +$338 0.02% 119
2025
Q3 		$69.8K Sell
211
-148
-41% -$46K 0.01% 129
2025
Q2 		$124K Buy
359
+1
+0.3% +$402 0.03% 99
2025
Q1 		$158K Buy
358
+2
+0.6% +$803 0.04% 82
2024
Q4 		$132K Sell
356
-29
-8% -$12.1K 0.03% 93
2024
Q3 		$191K Buy
385
+51
+15% +$27.2K 0.05% 82
2024
Q2 		$177K Buy
334
+14
+4% +$7.4K 0.04% 78
2024
Q1 		$174K Sell
320
-188
-37% -$93.5K 0.05% 79
2023
Q4 		$241K Buy
508
+1
+0.2% +$462 0.08% 71
2023
Q3 		$228K Buy
507
+1
+0.2% +$454 0.08% 74
2023
Q2 		$225K Buy
506
+1
+0.2% +$461 0.09% 78
2023
Q1 		$232K Buy
505
+1
+0.2% +$476 0.1% 81
2022
Q4 		$258K Buy
504
+1
+0.2% +$508 0.13% 72
2022
Q3 		$237K Buy
503
+1
+0.2% +$478 0.15% 69
2022
Q2 		$242K Buy
502
+2
+0.4% +$989 0.16% 66
2022
Q1 		$237K Hold
500
– – 0.15% 68
2021
Q4 		$237K Buy
500
+60
+14% +$25.2K 0.15% 68
2021
Q3 		$191K Buy
+440
New +$167K 0.11% 81

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kozak & Associates's ELV Position: Q2 2026 in Review

Kozak & Associates reduced its Elevance Health (ELV) stake by 70% in Q2 2026, selling an estimated $55.3K and leaving 64 shares worth $26.5K. The position accounts for ﹤0.01% of the portfolio, ranked #183.

Kozak & Associates first reported a position in ELV in Q3 2021 and has held it in 20 quarters since. The position peaked at $258K in Q4 2022. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Kozak & Associates held 64 shares of Elevance Health worth $26.5K as of Q2 2026.
  • Kozak & Associates sold 149 Elevance Health shares in Q2 2026, an estimated $55.3K.
  • Elevance Health made up ﹤0.01% of Kozak & Associates's portfolio in Q2 2026, its #183 holding.
  • Kozak & Associates first reported a position in Elevance Health in Q3 2021 and has held it in 20 quarters since.
  • Kozak & Associates's Elevance Health position peaked at $258K in Q4 2022.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Kozak & Associates's 13F filing for Q2 2026, filed 2 Jul 2026.